Lund, Sweden

Sara Ek


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Sara Ek: Pioneering Advances in Lymphoma Research

Introduction: Sara Ek, an accomplished inventor based in Lund, Sweden, has made significant strides in the field of biomedical innovations. With a focus on lymphoma research, she has developed a patent that addresses crucial aspects of imaging and diagnosing malignant lymphomas.

Latest Patents: Sara Ek holds a patent entitled "Sox11 expression in malignant lymphomas." This invention provides a binding moiety that selectively binds to the Sox11 protein and/or mRNA, which is pivotal for the imaging, diagnosis, and prognosis of lymphomas, including mantle cell lymphomas (MCL) and diffuse large B-cell lymphoma (DLBCL). The binding moiety can be an antibody or an antigen-binding fragment, and it may comprise a readily detectable moiety. Additionally, the patent encompasses methods for imaging lymphoma cells, diagnosing or prognosing lymphomas in individuals, and identifying lymphoma-associated cells by analyzing gene expression patterns against known lymphoma cell profiles.

Career Highlights: Sara Ek's contribution to the realm of lymphoma research is noteworthy, with her innovations positioning her as a vital figure in the field of diagnostic and therapeutic developments. Her patent demonstrates her commitment to improving the accuracy and effectiveness of lymphoma treatments, which has the potential to enhance patient outcomes.

Collaborations: In her professional journey, Sara collaborates closely with Carl Arne Krister Borrebaeck at Immunovia AB. This collaboration fosters a dynamic environment for innovation and research, where both individuals work synergistically to further advancements in lymphoma diagnostics.

Conclusion: Sara Ek stands out as a prominent inventor whose work has the potential to reshape the way malignant lymphomas are diagnosed and treated. Her pioneering efforts, underpinned by her patent on Sox11 expression, reflect her dedication to impactful medical advances that aim to benefit patients suffering from lymphoma.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…